What's happening
This bill directs New York's health, mental health, disabilities, and education commissioners to study the effects and diagnosis rates of medications prescribed for ADD and ADHD in school-age children.
Why it matters
Broadens the scope of research. beyond just ADD/ADHD stimulant medications to include selective serotonin reuptake inhibitors (SSRIs), antidepressants, and other drugs, which could impact how mental health treatments for children are understood and regulated.
Examines both medical effects and diagnostic practices. , focusing on harmful side effects, the tools and methods used for diagnosis, and the suitability of various medications—potentially informing future guidelines for safer, more accurate treatment and diagnosis of these conditions in kids.
Addresses demographic disparities. , requiring the study to consider whether certain groups of children are being diagnosed or medicated at different rates, which could highlight inequities or biases in current healthcare and educational systems.
Requires a coordinated, multi-agency approach. , ensuring perspectives from health, mental health, disabilities, and education sectors, which may lead to more comprehensive policy recommendations and reforms.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Study ADHD Drug Effects
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Study ADHD Meds for Kids
In Senate Committee · Health · Sponsor Kevin S. Parker
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1969
2023-2024 Regular Sessions
IN ASSEMBLY
January 23, 2023
Introduced by M. of A. WALKER, JEAN-PIERRE, STECK, SANTABARBARA, COOK -read once and referred to the Committee on Health
AN ACT authorizing and directing the department of health to do research and study as to the effects of psychostimulants, selective seratonin reuptake inhibitors, antidepressants and other drugs which are prescribed for attention deficit disorders, ADD and ADHD, for school age children
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. 1. The commissioner of health, in conjunction with the commissioner of mental health, the commissioner of developmental disabilities, and the commissioner of education is authorized and directed to conduct a study and do research as to the effect of psychostimulants, selective serotonin reuptake inhibitors, antidepressants and other drugs prescribed for attention deficit disorder, attention deficit hyperactivity disorder, and the increasing rate of diagnosis of these conditions, in school age children.
2. The study shall be conducted in accordance with rules, regulations and standards determined by the commissioner of health, and the study shall concentrate on harmful side effects of such drugs, the appropriateness and effectiveness of tools and methods used to assess and diagnose the condition, the appropriateness of different medications, and any demographic disparities in diagnosis.
3. The commissioner of health shall report his or her findings to the governor, the speaker of the assembly and the temporary president of the senate on or before two years from the date this act shall take effect.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD05576-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.